Gravemann U et al., 2022-09-20: Spike study showing the THERAFLEX MB-Plasma system inactivates quasi-enveloped hepatitis E virus in human plasma at light doses from 30 to 120 J/cm2.
Even the lowest light dose of 30 J/cm2 inactivated HEV down to the limit of detection, with a mean log reduction factor of greater than 2.4 for the total process.
Abstract
Gravemann U et al., 2022-09-20: Spike study showing the THERAFLEX MB-Plasma system inactivates quasi-enveloped hepatitis E virus in human plasma at light doses from 30 to 120 J/cm2. Study type: in vitro virus-spiking study on human plasma units; no human subjects. Country: Germany (German Red Cross Blood Service and Ruhr University Bochum). Light doses tested 30, 60, 90, 120 J/cm2 with the THERAFLEX MB-Plasma system; log reduction factor >2.4 at 30 J/cm2. Funding/COI not in retrieved abstract record; Macopharma collaboration is standard for this group. Comparator: untreated spiked plasma. Study type: lab.
